Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38244540)

  • 1. UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.
    Liu S; Chai T; Garcia-Marques F; Yin Q; Hsu EC; Shen M; Shaw Toland AM; Bermudez A; Hartono AB; Massey CF; Lee CS; Zheng L; Baron M; Denning CJ; Aslan M; Nguyen HM; Nolley R; Zoubeidi A; Das M; Kunder CA; Howitt BE; Soh HT; Weissman IL; Liss MA; Chin AI; Brooks JD; Corey E; Pitteri SJ; Huang J; Stoyanova T
    Cell Rep Med; 2024 Feb; 5(2):101381. PubMed ID: 38244540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin C-terminal hydrolase-L1 has prognostic relevance and is a therapeutic target for high-grade neuroendocrine lung cancers.
    Shimada Y; Kudo Y; Maehara S; Matsubayashi J; Otaki Y; Kajiwara N; Ohira T; Minna JD; Ikeda N
    Cancer Sci; 2020 Feb; 111(2):610-620. PubMed ID: 31845438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin C-terminal hydrolase L1 promotes lymph node metastasis in small cell neuroendocrine carcinomas of the cervix.
    Zhang Y; Ding J; Zhang X; Hua K
    J Int Med Res; 2022 Apr; 50(4):3000605221087620. PubMed ID: 35400238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin carboxy-terminal hydrolase L1 - physiology and pathology.
    Matuszczak E; Tylicka M; Komarowska MD; Debek W; Hermanowicz A
    Cell Biochem Funct; 2020 Jul; 38(5):533-540. PubMed ID: 32207552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
    Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
    Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance.
    Lien HC; Wang CC; Lin CH; Lu YS; Huang CS; Hsiao LP; Yao YT
    Hum Pathol; 2013 Sep; 44(9):1838-48. PubMed ID: 23664488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
    Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase.
    Ding X; Gu Y; Jin M; Guo X; Xue S; Tan C; Huang J; Yang W; Xue M; Zhou Q; Wang W; Zhang Y
    Theranostics; 2020; 10(13):6048-6060. PubMed ID: 32483437
    [No Abstract]   [Full Text] [Related]  

  • 9. UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma.
    Yao J; Reyimu A; Sun A; Duoji Z; Zhou W; Liang S; Hu S; Wang X; Dai J; Xu X
    World J Surg Oncol; 2022 May; 20(1):153. PubMed ID: 35546675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin C-Terminal Hydrolase L1 regulates autophagy by inhibiting autophagosome formation through its deubiquitinating enzyme activity.
    Yan C; Huo H; Yang C; Zhang T; Chu Y; Liu Y
    Biochem Biophys Res Commun; 2018 Mar; 497(2):726-733. PubMed ID: 29462615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.
    Finnerty BM; Moore MD; Verma A; Aronova A; Huang S; Edwards DP; Chen Z; Seandel M; Scognamiglio T; Du YN; Elemento O; Zarnegar R; Min IM; Fahey TJ
    Endocr Relat Cancer; 2019 Apr; 26(4):411-423. PubMed ID: 30689542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma.
    Zheng S; Qiao G; Min D; Zhang Z; Lin F; Yang Q; Feng T; Tang L; Sun Y; Zhao H; Li H; Yu W; Yang Y; Shen Z; Yao Y
    Cancer Lett; 2015 Apr; 359(1):36-46. PubMed ID: 25578779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deubiquitinase UCHL1 Maintains Protein Homeostasis through the PSMA7-APEH-Proteasome Axis in High-grade Serous Ovarian Carcinoma.
    Tangri A; Lighty K; Loganathan J; Mesmar F; Podicheti R; Zhang C; Iwanicki M; Drapkin R; Nakshatri H; Mitra S
    Mol Cancer Res; 2021 Jul; 19(7):1168-1181. PubMed ID: 33753553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.
    Ummanni R; Jost E; Braig M; Lohmann F; Mundt F; Barett C; Schlomm T; Sauter G; Senff T; Bokemeyer C; Sültmann H; Meyer-Schwesinger C; Brümmendorf TH; Balabanov S
    Mol Cancer; 2011 Oct; 10():129. PubMed ID: 21999842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis.
    Liu S; González-Prieto R; Zhang M; Geurink PP; Kooij R; Iyengar PV; van Dinther M; Bos E; Zhang X; Le Dévédec SE; van de Water B; Koning RI; Zhu HJ; Mesker WE; Vertegaal ACO; Ovaa H; Zhang L; Martens JWM; Ten Dijke P
    Clin Cancer Res; 2020 Mar; 26(6):1460-1473. PubMed ID: 31857432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UCHL1, a deubiquitinating enzyme, regulates lung endothelial cell permeability in vitro and in vivo.
    Mitra S; Epshtein Y; Sammani S; Quijada H; Chen W; Bandela M; Desai AA; Garcia JGN; Jacobson JR
    Am J Physiol Lung Cell Mol Physiol; 2021 Apr; 320(4):L497-L507. PubMed ID: 33438509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin C-terminal hydrolase L1 promotes expression of programmed cell death-ligand 1 in non-small-cell lung cancer cells.
    Mao R; Tan X; Xiao Y; Wang X; Wei Z; Wang J; Wang X; Zhou H; Zhang L; Shi Y
    Cancer Sci; 2020 Sep; 111(9):3174-3183. PubMed ID: 32539182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin carboxyl-terminal hydrolase L1 promotes hypoxia-inducible factor 1-dependent tumor cell malignancy in spheroid models.
    Li X; Hattori A; Takahashi S; Goto Y; Harada H; Kakeya H
    Cancer Sci; 2020 Jan; 111(1):239-252. PubMed ID: 31729096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.
    Takami Y; Nakagami H; Morishita R; Katsuya T; Cui TX; Ichikawa T; Saito Y; Hayashi H; Kikuchi Y; Nishikawa T; Baba Y; Yasuda O; Rakugi H; Ogihara T; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2184-90. PubMed ID: 17690318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin C-terminal hydrolase L1 (UCHL1), a double-edged sword in mammalian oocyte maturation and spermatogenesis.
    Yang D; Lu Q; Peng S; Hua J
    Cell Prolif; 2023 Feb; 56(2):e13347. PubMed ID: 36218038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.